Inyoung Youn

Dr. Inyoung Youn


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 April 2019 in British Journal of Radiology
Verified
Journal Article
Closed access
IYInyoung Youn
Inyoung Youn
SCSeonHyeong Choi
SeonHyeong Choi
YCYoon Jung Choi
Yoon Jung Choi
JMJu Hee Moon
Ju Hee Moon
HPHee Jin Park
Hee Jin Park
SKShin Ho Kook
Shin Ho Kook
Objective: To compare the accuracy of contrast-enhanced digital mammography (CEDM) and MRI, including maximal intensity projection (MIP) images, for measuring the tumour size of breast cancer. Meth...

1 January 2016 in Journal of Korean Medical Science
Verified
Journal Article
Open access
PDF file
IYInyoung Youn
Inyoung Youn
SCSeonHyeong Choi
SeonHyeong Choi
SKShin Ho Kook
Shin Ho Kook
YCYoon Jung Choi
Yoon Jung Choi
Youn I, et al. J Korean Med Sci. 2016 Mar;31(3):457-462. http://dx.doi.org/10.3346/jkms.2016.31.3.457


1 February 2024 in Radiology
Verified
Journal Article
Closed access
IYInyoung Youn
Inyoung Youn
DBDebosmita Biswas
Debosmita Biswas
DHDaniel S Hippe
Daniel S Hippe
AWAndrea M. Winter
Andrea M. Winter
AKAnum Kazerouni
Anum Kazerouni
SPSavannah Corrina Partridge
Savannah Corrina Partridge
Background The Eastern Cooperative Oncology Group-American College of Radiology Imaging Network Cancer Research Group multicenter A6702 trial identified an optimal apparent diffusion coefficient (ADC) cutoff to potentially reduce biopsies by 21% without affecting sensitivity. Whether this performance can be achieved in clinical settings has not yet been established. Purpose To validate the performance of point-of-care ADC measurements with the A6702 trial ADC cutoff for reducing unnecessary biopsies in lesions detected at breast MRI. Materials and Methods Consecutive breast MRI examinations performed from May 2015 to January 2019 at a single medical center and showing biopsy-confirmed Breast Imaging Reporting and Data System category 4 or 5 lesions, without ipsilateral cancer, were identified. Point-of-care lesion ADC measurements collected at clinical interpretation were retrospectively evaluated. MRI examinations included axial T2-weighted, diffusion-weighted, and dynamic contrast-enhanced sequences. Sensitivity and biopsy reduction rates were calculated by applying the A6702 optimal (ADC, 1.53 × 10-3 mm2/sec) and alternate conservative (1.68 × 10-3 mm2/sec) cutoffs. Lesion pathologic outcomes were the reference standard. To assess reproducibility, one radiologist repeated ADC measurements, and agreement was summarized using the intraclass correlation coefficient. Results A total of 240 lesions in 201 women (mean age, 49 years ± 13 [SD]) with pathologic outcomes (63 malignant and 177 benign) were included. Applying the optimal ADC cutoff produced an overall biopsy reduction rate of 15.8% (38 of 240 lesions [95% CI: 11.2, 20.9]), with a sensitivity of 92.1% (58 of 63 lesions [95% CI: 82.4, 97.4]; sensitivity was 97.2% [35 of 36 lesions] [95% CI: 82.7, 99.6] for invasive cancers). Results were similar for screening versus diagnostic examinations (P = .92 and .40, respectively). Sensitivity was higher for masses than for nonmass enhancements (NMEs) (100% vs 85.3%; P = .009). Applying the conservative ADC cutoff achieved a sensitivity of 95.2% (60 of 63 lesions [95% CI: 86.7, 99.0]), with a biopsy reduction rate of 10.4% (25 of 240 lesions [95% CI: 6.7, 14.5]). Repeated single-reader measurements showed good agreement with clinical ADCs (intraclass correlation coefficient, 0.72 [95% CI: 0.58, 0.81]). Conclusion This study validated the clinical use of ADC cutoffs to reduce MRI-prompted biopsies by up to 16%, with a suggested tradeoff of lowered sensitivity for in situ and microinvasive disease manifesting as NME. Clinical trial registration no. NCT02022579 © RSNA, 2024 Supplemental material is available for this article. See also the editorial by Honda and Iima in this issue.

7 October 2023 in Academic Radiology
Verified
Journal Article
Closed access
MKMi-ri Kwon
Mi-ri Kwon
IYInyoung Youn
Inyoung Youn
MLMi Yeon Lee
Mi Yeon Lee
HLHyun-Ah Lee
Hyun-Ah Lee

1 July 2024 in Radiology
Verified
Journal Article
Closed access
SHSu Min Ha
Su Min Ha
MJMyoung-Jin Jang
Myoung-Jin Jang
IYInyoung Youn
Inyoung Youn
HYHeera Yoen
Heera Yoen
HJHye Ji
Hye Ji
JCJung Min Chang
Jung Min Chang
Supplemental screening US demonstrated additional node-negative early breast cancers that were overlooked by mammography and artificial intelligence in women with dense breasts, while increasing false-positive findings.